Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.
| Image |  |
|---|---|
| Description | scientific article published on 19 November 2013 |
| Author/s |
author: Francesco Zaja Stefano Molica Francesca Romana Mauro Ilaria Del Giudice Mauro Nanni Roberto Marasca Anna Guarini Antonio Cuneo Robin Foà Agostino Cortelezzi Sabina Chiaretti Irene Della Starza Caterina Musolino Alfonso Piciocchi Marilisa Marinelli Maura Brugiatelli Marco Vignetti Francesco Albano |
| Publication date | November 19, 2013 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |